In April 2021, the FDA announced approval of an application for a produce to deliver an 8 milligram (mg) dose of naloxone; previous approvals had been granted for products delivering 2 mg and 4 mg of naloxone. The approval was granted to provide an additional option for the treatment of opioid overdose.
Funding Source: U.S. Food and Drug Administration
Approval of Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
A link to the announcement approving higher dosage of naloxone nasal spray to treat opioid overdose from the US Food and Drug Administration (FDA)